Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1974 Oct;180(4):384–392. doi: 10.1097/00000658-197410000-00002

Ten Years Clinical Experience with Partial Ileal Bypass in Management of the Hyperlipidemias

Henry Buchwald, Richard B Moore, Richard L Varco
PMCID: PMC1344105  PMID: 4416064

Abstract

The first partial ileal bypass operation specifically for the reduction of plasma lipids was performed by us in 1963. Since then we have operated upon and followed for more than three months 126 hyperlipidemic patients. Clinical metabolic studies, before and after the procedure, have demonstrated a 60% decrease in cholesterol absorption, a 3.8-fold increase in total fecal steroid excretion, a 5.7-fold increase in cholesterol synthesis, a 3-fold increase in cholesterol turnover, and a one-third decrease in the miscible cholesterol pool. Circulating cholesterol levels have been lowered an average 41.1% from the preoperative but postdietary baseline. An average 53% cholesterol reduction has been achieved from a pretreatment baseline using a combination of dietary and surgical management. Plasma triglycerides have been reduced in primary hypertriglyceridemic patients (type IV) an average of 52.6% from their preoperative but postdietary baseline. One patient died in the hospital and there have been 13 late deaths over the past 10 years. Four cases of postoperative bowel obstruction required reoperation. Diarrhea following partial ileal bypass is, as a rule, transistory and not a significant problem. No appreciable weight loss results from partial ileal bypass, which is an obvious distinction from the results of the far more massive jejuno-ileal bypass procedure for obesity. We have not encountered hepatotoxic, lithogenic, or nephrolithiasis complications in our partial ileal bypass patients. Sixty-nine per cent of our patients with preoperative angina pectoris have postoperative improvement or total remission of this symptom complex. Serial appraisal of followup coronary arteriographic studies offers preliminary evidence for lesion regression. It is concluded that partial ileal bypass is the most effective means for lipid reduction available today; it is obligatory in its actions, safe, and associated with minimal side effects.

Full text

PDF
384

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUCHWALD H., GEBHARD R. L. EFFECT OF INTESTINAL BYPASS ON CHOLESTEROL ABSORPTION AND BLOOD LEVELS IN THE RABBIT. Am J Physiol. 1964 Sep;207:567–572. doi: 10.1152/ajplegacy.1964.207.3.567. [DOI] [PubMed] [Google Scholar]
  2. Balfour J. F., Kim R. Homozygous type II hyperlipoproteinemia treatment. Partial ileal bypass in two children. JAMA. 1974 Mar 11;227(10):1145–1151. [PubMed] [Google Scholar]
  3. Baltaxe H. A., Amplatz K., Varco R. L., Buchwald H. Coronary arteriography in hypercholesterolemic patients. Am J Roentgenol Radium Ther Nucl Med. 1969 Apr;105(4):784–790. doi: 10.2214/ajr.105.4.784. [DOI] [PubMed] [Google Scholar]
  4. Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915. [PMC free article] [PubMed] [Google Scholar]
  5. Buchwald H., Moore R. B., Lee G. B., Baltaxe H., Amplatz K., Frantz I. D., Varco R. L. Five years experience with the use of partial ileal bypass in the treatment of hypercholesterolemia and atherosclerosis. Isr J Med Sci. 1969 Jul-Aug;5(4):760–765. [PubMed] [Google Scholar]
  6. Buchwald H. The dumping syndrome and its treatment. A review and presentation of cases. Am J Surg. 1968 Jul;116(1):81–88. doi: 10.1016/0002-9610(68)90422-4. [DOI] [PubMed] [Google Scholar]
  7. Buchwald H., Varco R. L. Ileal bypass in patients with hypercholesterolemia and atherosclerosis. Preliminary report on therapeutic potential. JAMA. 1966 May 16;196(7):627–630. [PubMed] [Google Scholar]
  8. Buchwald H., Varco R. L. Partial ileal bypass for hypercholesterolemia and atherosclerosis. Surg Gynecol Obstet. 1967 Jun;124(6):1231–1238. [PubMed] [Google Scholar]
  9. CHAPMAN J. M., GOERKE L. S., DIXON W., LOVELAND D. B., PHILLIPS E. Measuring the risk of coronary heart disease in adult population groups. The clinical status of a population group in Los Angeles under observation for two to three years. Am J Public Health Nations Health. 1957 Apr;47(4 Pt 2):33–42. doi: 10.2105/ajph.47.4_pt_2.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Clot J. P., Rouffy J., Loeper J., Mercadier M. Dérivation iléale, thérapeutique chirurgicale des hypercholestérolémies pures majeures (à propos de deux observations) Chirurgie. 1971 Feb 13;97(1):57–63. [PubMed] [Google Scholar]
  11. DAWBER T. R., MOORE F. E., MANN G. V. Coronary heart disease in the Framingham study. Am J Public Health Nations Health. 1957 Apr;47(4 Pt 2):4–24. doi: 10.2105/ajph.47.4_pt_2.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DOYLE J. T., HESLIN A. S., HILLEBOE H. E., FORMEL P. F., KORNS R. F. A prospective study of degenerative cardiovascular disease in Albany: report of three years' experience. I. Ischemic heart disease. Am J Public Health Nations Health. 1957 Apr;47(4 Pt 2):25–32. doi: 10.2105/ajph.47.4_pt_2.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fallon H. J., Woods J. W. Response of hyperlipoproteinemia to cholestyramine resin. JAMA. 1968 Jun 24;204(13):1161–1164. [PubMed] [Google Scholar]
  14. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 19;276(3):148–contd. doi: 10.1056/NEJM196701192760305. [DOI] [PubMed] [Google Scholar]
  15. Fritz S. H., Walker W. J. Ileal bypass in the control of intractable hypercholesterolemia. Clinical evaluation and case report. Am Surg. 1966 Oct;32(10):691–694. [PubMed] [Google Scholar]
  16. Goodman D. S., Noble R. P. Turnover of plasma cholesterol in man. J Clin Invest. 1968 Feb;47(2):231–241. doi: 10.1172/JCI105719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Grundy S. M. Treatment of hypercholesterolemia by interference with bile acid metabolism. Arch Intern Med. 1972 Oct;130(4):638–648. [PubMed] [Google Scholar]
  18. Helsingen N., Jr, Rootwelt K. Partial ileal by-pass. Kirurgisk behandling av hyperkolesterolemi. Nord Med. 1969 Nov 6;82(45):1409–1415. [PubMed] [Google Scholar]
  19. Hunninghake D. B., Tucker D. R., Azarnoff D. L. Long-term effects of clofibrate (Atromid-S) on serum lipids in man. Circulation. 1969 May;39(5):675–683. doi: 10.1161/01.cir.39.5.675. [DOI] [PubMed] [Google Scholar]
  20. Jeffcoate T. N., Miller J., Roos R. F., Tindall V. R. Puerperal thromboembolism in relation to the inhibition of lactation by oestrogen therapy. Br Med J. 1968 Oct 5;4(5622):19–25. doi: 10.1136/bmj.4.5622.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Knight L., Scheibel R., Amplatz K., Varco R. L., Buchwald H. Radiographic appraisal of the Minnesota partial ileal bypass study. Surg Forum. 1972;23(0):141–142. [PubMed] [Google Scholar]
  22. Krasno L. R., Kidera G. J. Clofibrate in coronary heart disease. Effect on morbidity and mortality. JAMA. 1972 Feb 14;219(7):845–851. [PubMed] [Google Scholar]
  23. Langer T., Levy R. I. Acute muscular syndrome associated with administration of clofibrate. N Engl J Med. 1968 Oct 17;279(16):856–858. doi: 10.1056/NEJM196810172791604. [DOI] [PubMed] [Google Scholar]
  24. Levy R. I., Fredrickson D. S. The current status of hypolipidemic drugs. Postgrad Med. 1970 Jan;47(1):130–136. doi: 10.1080/00325481.1970.11698102. [DOI] [PubMed] [Google Scholar]
  25. MATTHEWS C. M. The theory of tracer experiments with 131I-labelled plasma proteins. Phys Med Biol. 1957 Jul;2(1):36–53. doi: 10.1088/0031-9155/2/1/305. [DOI] [PubMed] [Google Scholar]
  26. Moore R. B., Frantz I. D., Jr, Buchwald H. Changes in cholesterol pool size, turnover rate, and fecal bile acid and sterol excretion after partial ileal bypass in hypercholesteremic patients. Surgery. 1969 Jan;65(1):98–108. [PubMed] [Google Scholar]
  27. Nygaard K., Helsingen N., Rootwelt K. Adaptation of vitamin B12 absorption after ileal bypass. Scand J Gastroenterol. 1970;5(5):349–351. [PubMed] [Google Scholar]
  28. RUSS E. M., EDER H. A., BARR D. P. Influence of gonadal hormones on protein-lipid relationships in human plasma. Am J Med. 1955 Jul;19(1):4–24. doi: 10.1016/0002-9343(55)90270-9. [DOI] [PubMed] [Google Scholar]
  29. STAMLER J., PICK R., KATZ L. N., PICK A., KAPLAN B. M., BERKSON D. M., CENTURY D. Effectiveness of estrogens for therapy of myocardial infarction in middle-age men. JAMA. 1963 Feb 23;183:632–638. doi: 10.1001/jama.1963.03700080040013. [DOI] [PubMed] [Google Scholar]
  30. STEINBERG D. Chemotherapeutic control of serum lipid levels. Trans N Y Acad Sci. 1962 Apr;24:704–723. doi: 10.1111/j.2164-0947.1962.tb01908.x. [DOI] [PubMed] [Google Scholar]
  31. Steinbach J. H., Blackshear P. L., Jr, Varco R. L., Buchwald H. High blood cholesterol reduces in vitro blood oxygen delivery. J Surg Res. 1974 Feb;16(2):134–139. doi: 10.1016/0022-4804(74)90021-3. [DOI] [PubMed] [Google Scholar]
  32. Strisower E. H., Kradjian R. M., Nichols A. V., Coggiola E., Tsai J. Effect of ileal bypass on serum lipoproteins in essential hypercholesterolemia. J Atheroscler Res. 1968 May-Jun;8(3):525–534. doi: 10.1016/s0368-1319(68)80106-1. [DOI] [PubMed] [Google Scholar]
  33. Södal G., Gjertsen K. T., Schrumpf A. Surgical treatment of hypercholesterolemia. Acta Chir Scand. 1970;136(8):671–674. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES